Exelixis, Inc. (NASDAQ:EXEL)
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
advanzio
(63.52)
Submitted: 3/14/2008 11:58:37 AM :
Start Price:
$5.41
EXEL Score:
-20.90
They have loaded up their guns and all they need is one or two good hits to make a bigger splash.
Recs
Raldogg
(58.58)
Submitted: 3/14/2008 12:11:37 AM :
Start Price:
$6.42
EXEL Score:
-31.88
Deep pipeline, improving balance sheet, likely to have a pre-ASCO bounce.
Recs
38usc
(49.62)
Submitted: 3/12/2008 4:10:10 PM :
Start Price:
$5.31
EXEL Score:
-19.40
huge potential in the next year many drugs waiting for fda ok
Recs
sumdadace123
(24.43)
Submitted: 3/4/2008 10:40:08 PM :
Start Price:
$6.33
EXEL Score:
-30.36
Exelixis is excellent
Recs
Gatsby01
(26.92)
Submitted: 3/2/2008 10:05:31 PM :
Start Price:
$6.62
EXEL Score:
-33.76
This pick is definitely outside my comfort zone. I feel like I am betting on my golf game ( which is not that good) but I have bought a few mulligans to improve the odds. Thanks to the Fool for bringing it to my attention and explaiing the rationale for this potential racehorse.
I am on my way to the range to practice.
Recs
BRADYstocks
(80.73)
Submitted: 2/25/2008 9:26:18 PM :
Start Price:
$6.16
EXEL Score:
+25.84
This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.
Recs
Lamnidae
(59.38)
Submitted: 2/22/2008 4:33:52 PM :
Start Price:
$5.81
EXEL Score:
-22.23
With so much in the pipeline, this price is impossible to pass up.
Recs
TMFBiologyFool
(98.28)
Submitted: 2/22/2008 2:54:14 PM :
Start Price:
$5.82
EXEL Score:
-24.01
Down in the dumps and could stay there for a while, but looks like a good bet in the long (5+ years) range.
Recs
morningstarboy
(32.35)
Submitted: 2/21/2008 1:02:20 PM :
Start Price:
$6.05
EXEL Score:
-25.55
As of close of business on 2/20/08, this was a 5-star Morningstar stock trading at less than half of its Morningstar fair value.
Recs
Stueyh1122
(65.46)
Submitted: 2/20/2008 6:00:04 PM :
Start Price:
$6.32
EXEL Score:
-27.79
6.25. This is too good a price in my book.
Recs
POSinvest
(< 20)
Submitted: 2/14/2008 12:03:23 PM :
Start Price:
$6.90
EXEL Score:
-34.64
Has been pummeled recently for no particular reason. I've like this company, but really like it at this price. Pipeline is it's biggest asset.
Recs
stockreader
(76.66)
Submitted: 2/6/2008 5:42:37 PM :
Start Price:
$7.41
EXEL Score:
-39.36
Exelixis Inc. is probably the best place to be, when investing in biotechnology. I usually don't put my money in "hot" sectors, but this time I'm willing to make an exception because of the remarkable reputation this company enjoys. Recent price drop of approximately 40% is a good as any place to open a position. But let's not kid ourselves, this one is no sure thing (if there is such a thing).
Recs
Roadlesstravel
(< 20)
Submitted: 2/2/2008 9:34:32 AM :
Start Price:
$7.44
EXEL Score:
-36.93
Long play
Recs
bigsmooth
(70.21)
Submitted: 1/23/2008 3:12:08 PM :
Start Price:
$7.26
EXEL Score:
-40.88
good pipeline, low price, works with a lot of bigger partners and doesn't need a lot of success to break through.
Recs
kurtismaximus
(86.12)
Submitted: 1/22/2008 4:58:02 PM :
Start Price:
$7.25
EXEL Score:
-44.74
has upcoming test that could be big but also has some risk, cheap to get in now.
Recs
nickzero
(< 20)
Submitted: 1/21/2008 1:58:20 PM :
Start Price:
$7.10
EXEL Score:
-43.29
R & D ing a lot of stuff. I like that theyre not banking on one or two drugs. Obviously, approval of one or two will skyrocket this company, but thats the rub. They have to GET there first. I still believe.
Recs
retireonexel
(42.70)
Submitted: 1/16/2008 11:41:28 AM :
Start Price:
$7.89
EXEL Score:
-42.10
The research and allies this company has is perfect for future growth. At its current price, you will get a steal.
Recs
Biotech2008
(72.48)
Submitted: 1/4/2008 10:01:15 PM :
Start Price:
$8.25
EXEL Score:
-41.20
atrio @ 9.61
Recs
kirchweih
(30.45)
Submitted: 12/14/2007 1:19:42 PM :
Start Price:
$9.54
EXEL Score:
-44.98
Wanted to have at least one speculative biotech pharma pick and this is it. MF rec, deep pipeline, blah, blah blah. Picking low-tide to put it in CAPS cuz I'm somewhat semi-mostly convinced they will strike gold. Just not anytime soon.
Disclosure: CAPS 4 me = RLP!
Recs
davilin07
(59.12)
Submitted: 12/10/2007 2:10:18 PM :
Start Price:
$8.67
EXEL Score:
-37.92
Still in a trading range that lasts for two years or so (before that it was in a slow uptrend) Nothing special except for the fact that the trading range goes from around 8$ to slightly over 12$, time and again, which is interesting if one has free cash to invest when it hits the 8$ bottom. It did again last week and now it's recovering again. Yes, the trading range could end pushing the stock down, but the news on Exelisis and their probable results with unless one of their drugs keeps being promising so not a bad decision to keep going with the crowd one more time. Anyway I waited a bit to see what happened after touching its bottom again, so I decided to enter at around 8.70 missing a previous 9% But a "rest" of 38% in the middle term is not a bad deal, is it?
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 161 - 180 of 392 : « Previous 4 5 6 7 8 9 10 11 12 13 Next »